United States Pharmaceuticals Market ANALYSE DE LA TAILLE ET DU PARTAGE - TENDANCES DE CROISSANCE ET PRÉVISIONS (2023 - 2030)

United States Pharmaceuticals Market is Segmented By Product Type (Prescription Drugs, Generic Drugs, OTC Drugs, Biologics, Biosimilars), By Therapy Area (Oncology, Diabetes, Autoimmune Diseases, Neurological Disorders, Cardiovascular, Infectious Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Parenteral, Topical), By End User (Hospitals, Clinics, Homecare Settings). The report offers the value (in USD billion) for the above-mentioned segments.

Competitive overview of United States Pharmaceuticals Market

Les principaux acteurs du marché américain des produits pharmaceutiques sont Johnson et Johnson Inc., Pfizer Inc., AbbVie Inc., Merck KGaA, Bristol-Myers Squibb Company, Amgen Inc., Eli Lilly and Company, Novartis AG, Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd., Sanofi, AstraZeneca, GSK plc., Bayer AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Abbott et Biogen

United States Pharmaceuticals Market Leaders

  • Johnson et Johnson Inc.
  • Pfizer Inc.
  • AbbVie Inc.
  • Merck KGaA
  • Bristol-Myers Squibb Company
*Disclaimer: Major players are listed in no particular order.

United States Pharmaceuticals Market - Competitive Rivalry, 2023

Market Concentration Graph

United States Pharmaceuticals Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights

United States Pharmaceuticals Market Report Snapshots

Buy Now